Jennifer L. Davis notified AbbVie of her intent to resign as a Class II director effective November 2, 2026, following her appointment as CEO of Align Technology.
Filing excerpt
On October 28, 2026, Jennifer L. Davis, a Class II director of AbbVie Inc. (“AbbVie”), notified the Company’s Board of Directors (the “Board”), of her intent to resign from the Board, effective November 2, 2026, in light of her recent appointment as Chief Executive Officer at Align Technology, Inc.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-8kboardChangeGet every 8-K signal for AbbVie and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at AbbVie this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/0edab7c6-5233-4278-a612-76b78a14ec54 returns this record as JSON. POST /v1/companies/enrich returns every signal for abbvie.com.
{
"signal_id": "0edab7c6-5233-4278-a612-76b78a14ec54",
"signal_type": "sec-8k",
"signal_subtype": "boardChange",
"detected_at": "2026-11-03T07:11:32.618+00:00",
"company": {
"name": "AbbVie",
"domain": "abbvie.com"
},
"data": {
"detail": "Jennifer L. Davis notified AbbVie of her intent to resign as a Class II director effective November 2, 2026, following her appointment as CEO of Align Technology. This board departure may prompt committee realignments and vendor or governance advisory evaluations.",
"metrics": {
"timeframe": "immediate"
},
"summary": "Class II Director Jennifer L. Davis Resigns from AbbVie Board Effective November 2, 2026",
"excerpts": "On October 28, 2026, Jennifer L. Davis, a Class II director of AbbVie Inc. (“AbbVie”), notified the Company’s Board of Directors (the “Board”), of her intent to resign from the Board, effective November 2, 2026, in light of her recent appointment as Chief Executive Officer at Align Technology, Inc.",
"relevance": 0.8,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465926121322/tm2628215d1_8k.htm",
"filing_date": "2026-11-02",
"filing_year": 2026,
"sales_relevance": "Strategic direction shift",
"signal_category": "leadership"
}
}
curl https://signals.autobound.ai/v1/signals/0edab7c6-5233-4278-a612-76b78a14ec54 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"abbvie.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.